AF
MTCR

Allworth Financial’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Allworth Financial’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-500
Closed -$224 – 3345
2022
Q4 		$224 Buy
+500
New +$207 ﹤0.01% 2768

Other funds holding MTCR

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Allworth Financial's MTCR Position: Q1 2023 in Review

Allworth Financial sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 500 shares — an estimated $224 sold.

Allworth Financial first reported a position in MTCR in Q4 2022 and held it in 1 quarter. The position peaked at $224 in Q4 2022. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.

  • Allworth Financial reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Allworth Financial sold 500 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $224.
  • Allworth Financial first reported a position in Metacrine, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Allworth Financial's Metacrine, Inc. Common Stock position peaked at $224 in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.

Based on Allworth Financial's 13F filing for Q1 2023, filed 18 Apr 2023.